share_log

啓明醫療-B：自願公告 有關未經授權貸款及質押存款的進一步更新

VENUS MEDTECH-B: VOLUNTARY ANNOUNCEMENT FURTHER UPDATE ON THE UNAUTHORIZED LOANS AND PLEDGED DEPOSITS

Hong Kong Stock Exchange ·  Apr 15 18:03
Summary by Moomoo AI
啓明醫疗-B（股份代號：2500）於2024年4月16日發布自願公告，更新關於未經授權貸款及質押存款的最新情況。該公司回顧了先前於2月25日及3月28日的公告，涉及向江蘇吳中的未經授權貸款和向Hangzhou Kuntai的未經授權擔保。啓明醫療宣布，其全資附屬公司杭州啓宜為Hangzhou Kuntai提供的人民幣1億元質押存款已獲銀行解除，並已提取該筆款項，同時獲得約人民幣205萬元的利息收入。此外，所有過往為貸款擔保而質押的定期存款亦已解除質押。公司目前正就剩餘的人民幣8000萬元貸款與相關方協商還款日期，並將於適時公布進一步消息。自2023年11月23日起，啓明醫療-B的股份交易已暫停，並將持續暫停直至符合聯交所的復牌指引。公司股東及潛在投資者被提醒在交易時需謹慎。
啓明醫疗-B（股份代號：2500）於2024年4月16日發布自願公告，更新關於未經授權貸款及質押存款的最新情況。該公司回顧了先前於2月25日及3月28日的公告，涉及向江蘇吳中的未經授權貸款和向Hangzhou Kuntai的未經授權擔保。啓明醫療宣布，其全資附屬公司杭州啓宜為Hangzhou Kuntai提供的人民幣1億元質押存款已獲銀行解除，並已提取該筆款項，同時獲得約人民幣205萬元的利息收入。此外，所有過往為貸款擔保而質押的定期存款亦已解除質押。公司目前正就剩餘的人民幣8000萬元貸款與相關方協商還款日期，並將於適時公布進一步消息。自2023年11月23日起，啓明醫療-B的股份交易已暫停，並將持續暫停直至符合聯交所的復牌指引。公司股東及潛在投資者被提醒在交易時需謹慎。
KAI MING MEDICAL-B (SHARE CODE: 2500) ISSUED A VOLUNTARY ANNOUNCEMENT ON 16 APRIL 2024 TO UPDATE THE SITUATION REGARDING UNAUTHORIZED LOANS AND COLLATERAL DEPOSITS. The Company reviewed previous announcements of February 25 and March 28 concerning unauthorized loans to Wuzhong of Jiangsu and unauthorized guarantees to Hangzhou Kuntai. Kai Ming Medical announced that its wholly-owned subsidiary Hangzhou Kaiyi's RMB 1 billion deposit to Hangzhou Kuntai had been liquidated by the bank and had withdrawn the amount, while receiving interest income of about RMB205 million. In addition, all fixed deposits that were previously pledged as collateral for the loan have also been de-collateralized. The Company is currently negotiating a repayment date for the remaining RMB 8000 million loan with relevant parties and will announce further information in due course. As of 23 November 2023, trading in Kai Ming Medical-B shares has been suspended and will continue to be suspended until compliance with the exchange's reauthorization guidelines. Company shareholders and potential investors are reminded to exercise caution when trading.
KAI MING MEDICAL-B (SHARE CODE: 2500) ISSUED A VOLUNTARY ANNOUNCEMENT ON 16 APRIL 2024 TO UPDATE THE SITUATION REGARDING UNAUTHORIZED LOANS AND COLLATERAL DEPOSITS. The Company reviewed previous announcements of February 25 and March 28 concerning unauthorized loans to Wuzhong of Jiangsu and unauthorized guarantees to Hangzhou Kuntai. Kai Ming Medical announced that its wholly-owned subsidiary Hangzhou Kaiyi's RMB 1 billion deposit to Hangzhou Kuntai had been liquidated by the bank and had withdrawn the amount, while receiving interest income of about RMB205 million. In addition, all fixed deposits that were previously pledged as collateral for the loan have also been de-collateralized. The Company is currently negotiating a repayment date for the remaining RMB 8000 million loan with relevant parties and will announce further information in due course. As of 23 November 2023, trading in Kai Ming Medical-B shares has been suspended and will continue to be suspended until compliance with the exchange's reauthorization guidelines. Company shareholders and potential investors are reminded to exercise caution when trading.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more